Wealthcare Advisory Partners LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1683059
WEST CHESTER, PA
Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,444,299
-$947,827 QoQ
Shares Held
19,347
-20.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#769
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealthcare Advisory Partners LLC holds $56,868,613 across 12 Drug Manufacturers - General names. GILD ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
50,422 | $12,688,192 | |
| 2 | LLY |
ELI LILLY & Co
|
10,304 | $12,358,927 | |
| 3 | JNJ |
Johnson & Johnson
|
37,978 | $9,645,272 | |
| 4 | AMGN |
Amgen Inc
|
15,360 | $5,562,163 | |
| 5 | MRK |
Merck & Co., Inc.
|
34,872 | $4,481,052 | |
| 6 | PFE |
Pfizer Inc
|
147,571 | $3,553,509 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
19,347 | $2,444,299 | |
| 8 | AZN |
Astrazeneca PLC
|
12,112 | $2,296,677 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,444,299 | 19,347 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,392,126 | 24,339 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $2,399,198 | 19,547 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,055,054 | 18,514 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,054,088 | 18,527 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,036,508 | 18,175 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,686,953 | 18,263 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,344,290 | 16,034 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,000,951 | 14,589 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,001,767 | 13,676 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,141,835 | 14,095 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,020,532 | 13,618 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,125,376 | 14,602 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,228,370 | 14,805 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,351,107 | 15,738 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $760,884 | 12,334 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $733,313 | 11,864 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $222,912 | 3,070 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $591,000 | 8,461 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $567,612 | 8,243 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $663,556 | 10,267 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $277,900 | 4,770 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $255,477 | 4,043 | Shares | Sole | 2020-10-29 | |
| 2020-03-31 | $164,845 | 2,205 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||